322 related articles for article (PubMed ID: 11346307)
1. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
Vigna SR
Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
[TBL] [Abstract][Full Text] [Related]
2. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
3. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
Sagan S; Chassaing G; Pradier L; Lavielle S
J Pharmacol Exp Ther; 1996 Mar; 276(3):1039-48. PubMed ID: 8786533
[TBL] [Abstract][Full Text] [Related]
4. The role of the amino-terminal domain of tachykinins in neurokinin-1 receptor signaling and desensitization.
Vigna SR
Neuropeptides; 2003 Feb; 37(1):30-5. PubMed ID: 12637033
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the pressor response to tachykinins in isolated perfused rat kidney.
Chen Y; Hoover DB
J Pharmacol Exp Ther; 1993 Dec; 267(3):1176-80. PubMed ID: 7505328
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M; Boczek-Leszczyk E
J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery.
Pedersen KE; Buckner CK; Meeker SN; Undem BJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):319-25. PubMed ID: 10604965
[TBL] [Abstract][Full Text] [Related]
8. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
Juszczak M; Boczek-Leszczyk E; Stempniak B
J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation and desensitization of neurokinin-1 receptor expressed in epithelial cells.
Vigna SR
J Neurochem; 1999 Nov; 73(5):1925-32. PubMed ID: 10537050
[TBL] [Abstract][Full Text] [Related]
10. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
11. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P.
Pradier L; Ménager J; Le Guern J; Bock MD; Heuillet E; Fardin V; Garret C; Doble A; Mayaux JF
Mol Pharmacol; 1994 Feb; 45(2):287-93. PubMed ID: 7509440
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
[TBL] [Abstract][Full Text] [Related]
13. Extracellular domains of the neurokinin-1 receptor: structural characterization and interactions with substance P.
Ulfers AL; Piserchio A; Mierke DF
Biopolymers; 2002; 66(5):339-49. PubMed ID: 12539262
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors.
Torrens Y; Beaujouan JC; Saffroy M; Glowinski J
Biochem Biophys Res Commun; 2000 Apr; 270(2):668-72. PubMed ID: 10753681
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
[TBL] [Abstract][Full Text] [Related]
16. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor.
Bremer AA; Leeman SE; Boyd ND
FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of vinylogous scaffolds in the C-terminal tripeptide of substance P.
Claudel S; Tasseau O; Sagan S; Grison C; Coutrot P; Lavielle S
J Pept Res; 2004 Nov; 64(5):186-93. PubMed ID: 15485556
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M
Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
[TBL] [Abstract][Full Text] [Related]
19. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis.
Hastrup H; Schwartz TW
FEBS Lett; 1996 Dec; 399(3):264-6. PubMed ID: 8985159
[TBL] [Abstract][Full Text] [Related]
20. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]